Firm intentionHealthcare20 July 2026

MedPal AI plc to acquire Solid State Technologies Ltd

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
MedPal AI plc
Target
Solid State Technologies Ltd
Deal value
GBP 474,000
Announced
20 July 2026
Status
Firm intention
Sector
Healthcare
Country
United Kingdom
Consideration
cash, shares
What we know

MedPal AI plc has agreed to acquire Solid State Technologies Ltd in a strategic acquisition valued at £474,000. The transaction, announced on 20 July 2026, involves a combination of cash and shares as the primary consideration for the deal. Both the acquiring entity and the target company are headquartered in the United Kingdom, indicating a domestic transaction within the healthcare sector. This arrangement represents a significant step for MedPal AI plc in expanding its operational footprint and capabilities within the domestic healthcare market. The structure of the deal suggests a focus on integrating Solid State Technologies Ltd’s assets and expertise into the broader strategic framework of the buyer. The headline offer value reflects the agreed terms between the parties, providing a clear financial baseline for the acquisition.

The transaction is currently at the firm intention stage, with no completion date yet established. Regulatory approvals and other customary closing conditions will need to be satisfied before the deal can proceed to completion. Stakeholders are awaiting further updates regarding the timeline for finalising the agreement and integrating the target business. The combination of cash and share consideration indicates a balanced approach to financing the acquisition, aligning the interests of both parties. This deal marks a notable development in the UK healthcare sector, highlighting ongoing consolidation and strategic growth initiatives among industry participants. The outcome will depend on successful negotiation of final terms and timely regulatory clearance.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. Firm intention

    Acquisition of eMARx

    Disclaimer*       20 July 2026 MedPal AI plc ("MedPal", the "Company" or the "Group") Acquisition of eMARx: the digital medication layer for the UK care home market Completes MedPal's Health OS across the care home sector and opens a national roll-out from the Group's robotic dispensing hub   MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, is

    LSE RNS

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

11 August 2026ClearedHealthcare

Dolby Medical Home Respiratory Care Limited (Vivisol) to acquire Air Liquide Healthcare Limited’s home oxygen services business

Dolby Medical Home Respiratory Care Limited, trading as Vivisol, has agreed to acquire the home oxygen services business of Air Liquide Healthcare Limited in a strategic…

Buyer
Dolby Medical Home Respiratory Care Limited (Vivisol)
Target
Air Liquide Healthcare Limited’s home oxygen services business
Deal value
Not disclosed
Deal type
strategic acquisition

Buyer history

MedPal AI plc

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive